Report Detail

Pharma & Healthcare Global (United States, European Union and China) Cancer Diagnostics Market Research Report 2019-2025

  • RnM3686115
  • |
  • 20 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. 
The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
In 2019, the market size of Cancer Diagnostics is 8990 million US$ and it will reach 23200 million US$ in 2025, growing at a CAGR of 12.6% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Diagnostics.

This report studies the global market size of Cancer Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard

Market Segment by Product Type
Platform-based
Instrument-based

Market Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Cancer Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Platform-based
      • 1.3.3 Instrument-based
    • 1.4 Market Segment by Application
      • 1.4.1 Global Cancer Diagnostics Market Share by Application (2019-2025)
      • 1.4.2 Breast Cancer
      • 1.4.3 Lung Cancer
      • 1.4.4 Colorectal Cancer
      • 1.4.5 Melanoma
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Cancer Diagnostics Market Size
      • 2.1.1 Global Cancer Diagnostics Revenue 2014-2025
      • 2.1.2 Global Cancer Diagnostics Sales 2014-2025
    • 2.2 Cancer Diagnostics Growth Rate by Regions
      • 2.2.1 Global Cancer Diagnostics Sales by Regions 2014-2019
      • 2.2.2 Global Cancer Diagnostics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Cancer Diagnostics Sales by Manufacturers
      • 3.1.1 Cancer Diagnostics Sales by Manufacturers 2014-2019
      • 3.1.2 Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Cancer Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Cancer Diagnostics Price by Manufacturers
    • 3.4 Key Manufacturers Cancer Diagnostics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Cancer Diagnostics Market
    • 3.6 Key Manufacturers Cancer Diagnostics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Platform-based Sales and Revenue (2014-2019)
      • 4.1.2 Instrument-based Sales and Revenue (2014-2019)
    • 4.2 Global Cancer Diagnostics Sales Market Share by Type
    • 4.3 Global Cancer Diagnostics Revenue Market Share by Type
    • 4.4 Cancer Diagnostics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Cancer Diagnostics Sales by Application

    6 United States

    • 6.1 United States Cancer Diagnostics Breakdown Data by Company
    • 6.2 United States Cancer Diagnostics Breakdown Data by Type
    • 6.3 United States Cancer Diagnostics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Cancer Diagnostics Breakdown Data by Company
    • 7.2 European Union Cancer Diagnostics Breakdown Data by Type
    • 7.3 European Union Cancer Diagnostics Breakdown Data by Application

    8 China

    • 8.1 China Cancer Diagnostics Breakdown Data by Company
    • 8.2 China Cancer Diagnostics Breakdown Data by Type
    • 8.3 China Cancer Diagnostics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Cancer Diagnostics Breakdown Data by Company
    • 9.2 Rest of World Cancer Diagnostics Breakdown Data by Type
    • 9.3 Rest of World Cancer Diagnostics Breakdown Data by Application
    • 9.4 Rest of World Cancer Diagnostics Breakdown Data by Countries
      • 9.4.1 Rest of World Cancer Diagnostics Sales by Countries
      • 9.4.2 Rest of World Cancer Diagnostics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Becton, Dickinson and Company
      • 10.1.1 Becton, Dickinson and Company Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.1.4 Cancer Diagnostics Product Introduction
      • 10.1.5 Becton, Dickinson and Company Recent Development
    • 10.2 GE Healthcare
      • 10.2.1 GE Healthcare Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.2.4 Cancer Diagnostics Product Introduction
      • 10.2.5 GE Healthcare Recent Development
    • 10.3 Abbott
      • 10.3.1 Abbott Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.3.4 Cancer Diagnostics Product Introduction
      • 10.3.5 Abbott Recent Development
    • 10.4 Roche
      • 10.4.1 Roche Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.4.4 Cancer Diagnostics Product Introduction
      • 10.4.5 Roche Recent Development
    • 10.5 Thermo Fisher Scientific
      • 10.5.1 Thermo Fisher Scientific Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.5.4 Cancer Diagnostics Product Introduction
      • 10.5.5 Thermo Fisher Scientific Recent Development
    • 10.6 Agilent Technologies
      • 10.6.1 Agilent Technologies Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.6.4 Cancer Diagnostics Product Introduction
      • 10.6.5 Agilent Technologies Recent Development
    • 10.7 Illumina
      • 10.7.1 Illumina Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.7.4 Cancer Diagnostics Product Introduction
      • 10.7.5 Illumina Recent Development
    • 10.8 Siemens Healthcare
      • 10.8.1 Siemens Healthcare Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.8.4 Cancer Diagnostics Product Introduction
      • 10.8.5 Siemens Healthcare Recent Development
    • 10.9 C.R. Bard
      • 10.9.1 C.R. Bard Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Cancer Diagnostics
      • 10.9.4 Cancer Diagnostics Product Introduction
      • 10.9.5 C.R. Bard Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Cancer Diagnostics Sales Channels
      • 11.2.2 Cancer Diagnostics Distributors
    • 11.3 Cancer Diagnostics Customers

    12 Market Forecast

    • 12.1 Global Cancer Diagnostics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Cancer Diagnostics Sales Forecast by Type
    • 12.3 Global Cancer Diagnostics Sales Forecast by Application
    • 12.4 Cancer Diagnostics Forecast by Regions
      • 12.4.1 Global Cancer Diagnostics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Cancer Diagnostics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Cancer Diagnostics. Industry analysis & Market Report on Cancer Diagnostics is a syndicated market report, published as Global (United States, European Union and China) Cancer Diagnostics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,535.44
      3,803.16
      5,070.88
      3,053.68
      4,580.52
      6,107.36
      500,823.20
      751,234.80
      1,001,646.40
      276,832.00
      415,248.00
      553,664.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report